Top compounds associated with response to CCDC102A

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.15	3e-05
mRNA	navitoclax:PLX-4032 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.14	6e-05
mRNA	MS-275	CTRPv2	pan-cancer	AAC	-0.13	7e-05
mRNA	NVP-BEZ235	GDSC1000	pan-cancer	AAC	0.13	0.0001
mRNA	Panobinostat	CTRPv2	pan-cancer	AAC	-0.13	0.0001
mRNA	JQ-1:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.13	0.0002
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.12	0.0002
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.13	0.0003
mRNA	selumetinib:vorinostat (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.13	0.0003
mRNA	ABT-199	CTRPv2	pan-cancer	AAC	-0.16	0.0003

Download CSV